CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 55 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,597 | -63.7% | 154,291 | -36.4% | 0.00% | – |
| Q2 2023 | $290,942 | +2660.6% | 242,452 | +1717.5% | 0.00% | – |
| Q4 2022 | $10,539 | -94.8% | 13,340 | -94.0% | 0.00% | – |
| Q2 2022 | $203,000 | -24.0% | 221,256 | +48.5% | 0.00% | – |
| Q1 2022 | $267,000 | +196.7% | 149,034 | +155.3% | 0.00% | – |
| Q4 2021 | $90,000 | -77.6% | 58,386 | -70.4% | 0.00% | – |
| Q3 2021 | $401,000 | +1.3% | 197,121 | +73.3% | 0.00% | – |
| Q2 2021 | $396,000 | +1000.0% | 113,764 | +882.9% | 0.00% | – |
| Q3 2017 | $36,000 | – | 11,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
| Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
| Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
| Freed Investment Group | 14,600 | $26,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
| LMR Partners LLP | 63,950 | $114,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
| Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |